Shares of Patanjali Foods climbed nearly 7 per cent in intra-day trade on Tuesday after wrong shareholding data for the quarter ending March indicated that US-based investment firm GQG Partners hiked its stake in the company. The stock jumped 5.41 per cent to settle at Rs 1,407.70 on the BSE. During the day, it climbed 6.63 per cent to Rs 1,424.10. At the NSE, it advanced 5 per cent to Rs 1,408.50. During the day, it zoomed 6.21 per cent to Rs 1,424. A filing was uploaded earlier in the day, which showed that GQG Partners Emerging Markets Equity Fund A Series of GQG Partners Series LLC have upped its stake to 9.31 per cent as on quarter ended March 31. The company later revised the shareholding pattern at 4:14:57 pm and gave reasons of typographical mistake in number of shares held by GQG Partners Emerging Markets Equity Fund A Series. The revised format showed that GQG Partners Emerging Markets Equity Fund has 1.02 per cent stake in the company. Last year in July, GQG Partners b
Though Ramdev and Balkrishna tendered apologies for their actions, the SC Bench hinted that their apology wasn't sufficient to absolve them of responsibility
Justice Hima Kohli further said that the licencing authority was hand in glove with Patanjali and did nothing "except pushing the file around
IndiGo now world's third largest airline, SC on Patanjali, BJP's 10th list & more Top News in 1 Min
Patanjali Ayurved founder Ramdev and MD Balkrishna have submitted affidavits offering 'unconditional, unqualified' apologies to the Supreme Court
Latest news updates: Catch all the news updates from around the world here
Wrap up your Tuesday with the top news stories in just 1 minute!
Ramdev submitted an unconditional apology to the Supreme Court, clarifying that Patanjali's intention was solely to encourage healthier living among citizens by promoting the use of its products
The court had earlier said that Ramdev and Balkrishna were in violation of Section 3 and 4 of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954
In an affidavit submitted to the Supreme Court, Balkrishna apologised for the misleading ads and claimed that the intention of the company was to solely promote Ayurveda
The Supreme Court summoned Baba Ramdev and Acharya Balkrishna to appear personally in court for failing to respond to a show cause notice in contempt proceedings
Patanjali Ayurved has faced scrutiny from the top court for disseminating misleading advertisements that claim to treat medical conditions, a violation of the Magic Remedies Act, 1954
Patanjali ad ban is the right remedy
The Supreme Court on Tuesday issued a contempt notice to Patanjali Ayurved and its MD Acharya Balakrishna for flouting earlier orders by continuing to propagate misleading claims via advertisements.
Stocks to watch on February 28, 2024: Juniper Hotels will make its market debut today; Vodafone Idea's board on Tuesday greenlit plans to raise up to Rs 45,000 crore in equity and debt
The Supreme Court had warned Patanjali Ayurved against disseminating 'false' and 'misleading' claims in its advertisements
However, the company's net sales saw a rise of 0.2 per cent to Rs 7,910.70 crore from Rs 7,926.64 in the year-ago period
The court held that anti profiteering provisions pertain to commensurate reduction of prices when gst rates are reduced or due to input tax credit and hence these provisions are in public interest
During the investor day, Ramdev also said that he cannot comment on the merger, demerger or acquisitions the company plans to make in Patanjali Foods
Supreme Court cautions Patanjali Ayurved against making "false" and "misleading" claims in ads. Watch the video to learn more >